scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1012615900 |
P356 | DOI | 10.1007/S00262-014-1557-4 |
P932 | PMC publication ID | 4200484 |
P698 | PubMed publication ID | 24841535 |
P2093 | author name string | Jing Yang | |
Mingjun Zhang | |||
Haiyan Li | |||
Jin He | |||
Yong Lu | |||
Jungsun Park | |||
Jianfei Qian | |||
Qing Yi | |||
Yuhuan Zheng | |||
Bangxing Hong | |||
P2860 | cites work | Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells | Q24601213 |
IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells | Q28590243 | ||
Cancer immunotherapy via dendritic cells | Q29615444 | ||
IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled | Q33941375 | ||
The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling | Q34304678 | ||
The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. | Q35105032 | ||
Th9 cells promote antitumor immune responses in vivo | Q36357944 | ||
TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo | Q36375923 | ||
Transcription factors mediating interleukin-3 survival signals | Q36617082 | ||
Cytokine receptors and hematopoietic differentiation | Q36970182 | ||
Th9 and allergic disease | Q37552040 | ||
Th9 cells: differentiation and disease. | Q37696777 | ||
The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells | Q38139199 | ||
Induction of antitumor immunity using dendritic cells electroporated with Polo-like kinase 1 (Plk1) mRNA in murine tumor models | Q39547514 | ||
IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line | Q40937398 | ||
Activation of human dendritic cells through CD40 cross-linking. | Q41440958 | ||
The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand | Q42012073 | ||
Dendritic cell survival and maturation are regulated by different signaling pathways. | Q42971737 | ||
Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway. | Q43829914 | ||
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. | Q44453951 | ||
A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells | Q47631638 | ||
The development, maturation, and turnover rate of mouse spleen dendritic cell populations. | Q52143353 | ||
The many lives of IL-9: a question of survival? | Q53161765 | ||
Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. | Q53446140 | ||
Increasing the Survival of Dendritic Cells In Vivo Does Not Replace the Requirement for CD4+ T Cell Help during Primary CD8+ T Cell Responses | Q62230764 | ||
Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions | Q73592527 | ||
A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern | Q74261397 | ||
Reciprocal control of T helper cell and dendritic cell differentiation | Q74452751 | ||
Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties | Q77536023 | ||
Dendritic cell apoptosis in the maintenance of immune tolerance | Q82647177 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
immunotherapy | Q1427096 | ||
P304 | page(s) | 835-845 | |
P577 | publication date | 2014-05-20 | |
P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
P1476 | title | Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy | |
P478 | volume | 63 |
Q64120462 | IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling |
Q89725109 | IL-9 and Th9 Cells in Tumor Immunity |
Q37706268 | Induction of specific T helper-9 cells to inhibit glioma cell growth |
Q92153231 | P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study |
Q37688655 | TH9 cell differentiation, transcriptional control and function in inflammation, autoimmune diseases and cancer. |
Q37575177 | TH9 cells in anti-tumor immunity |
Q40224209 | Th9 Cells: New Member of T Helper Cell Family. |
Q40690742 | Th9 cells: a new population of helper T cells |
Q28083375 | The development and in vivo function of T helper 9 cells |
Search more.